Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Todd Schlesinger, Eggert Stockfleth, Ayman Grada & Brian Berman. (2022) Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action. Clinical, Cosmetic and Investigational Dermatology 15, pages 2495-2506.
Read now
Read now
Federica Veronese, Elisa Zavattaro, Gionathan Orioni, Gianluca Landucci, Vanessa Tarantino, Chiara Airoldi & Paola Savoia. (2021) Efficacy of new class I medical device for actinic keratoses: a randomized controlled prospective study. Journal of Dermatological Treatment 32:6, pages 625-630.
Read now
Read now
Philipp Cramer & Eggert Stockfleth. (2020) Actinic keratosis: where do we stand and where is the future going to take us?. Expert Opinion on Emerging Drugs 25:1, pages 49-58.
Read now
Read now
Alicia D. Bucko, Michael Jarratt, Dowling B. Stough, Laerke Kyhl, John Villumsen & Anders Hall. (2018) Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas. Journal of Dermatological Treatment 29:1, pages 74-79.
Read now
Read now
Thomas Dirschka, Girish Gupta, Giuseppe Micali, Eggert Stockfleth, Nicole Basset-Séguin, Véronique Del Marmol, Reinhard Dummer, Gregor B. E. Jemec, Josep Malvehy, Ketty Peris, Susana Puig, Alexander J. Stratigos, Iris Zalaudek & Giovanni Pellacani. (2017) Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology. Journal of Dermatological Treatment 28:5, pages 431-442.
Read now
Read now
Peter Foley, Eggert Stockfleth, Ketty Peris, Nicole Basset-Seguin, Rino Cerio, José Antonio Sanches, Carlos Guillen, Emily Farrington & Mark Lebwohl. (2016) Adherence to topical therapies in actinic keratosis: A literature review. Journal of Dermatological Treatment 27:6, pages 538-545.
Read now
Read now
Gary Goldenberg. (2014) Optimal treatment of actinic keratosis. Clinical Interventions in Aging 9, pages 15-16.
Read now
Read now
Articles from other publishers (30)
Giovanni Pellacani, Ketty Peris, Silvana Ciardo, Claudia Pezzini, Sara Tambone, Francesca Farnetani, Caterina Longo, Camilla Chello & Salvador González. (2023)
The combination of oral and topical photoprotection with a standardized
Polypodium leucotomos
extract is beneficial against actinic keratosis
. Photodermatology, Photoimmunology & Photomedicine.
Crossref
Crossref
Domenico Arcuri, Brandon Ramchatesingh, François Lagacé, Lisa Iannattone, Elena Netchiporouk, Philippe Lefrançois & Ivan V. Litvinov. (2023) Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review. International Journal of Molecular Sciences 24:5, pages 4989.
Crossref
Crossref
Michael Ha, Emily R Finkelstein, Mark Wieland, Aasheen Qadri, Madeline Brown, Jason Ejimogu & Yvonne M Rasko. (2022) Insurance Coverage of Dermabrasion and Chemical Peel Procedures: A Critical Analysis of 58 American Insurance Companies. Cureus.
Crossref
Crossref
J. O’Callaghan, S. Cournane, J. McCavana & D. Cody. (2021) Theoretical design of an absorption hologram-based sensor for dose quantification in daylight photodynamic therapy. Journal of the Optical Society of America A 39:1, pages 127.
Crossref
Crossref
Martina Ulrich, Uwe Reinhold, Rolf Dominicus, Roland Aschoff, Rolf-Markus Szeimies & Thomas Dirschka. (2021) Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk, and neck in a vehicle-controlled phase III study. Journal of the American Academy of Dermatology 85:6, pages 1510-1519.
Crossref
Crossref
U. Reinhold, J. Bai-Habelski, D. Abeck, R. Denfeld, R. Dominicus, T. Fischer & P. Radny. (2021) Kaliumhydroxid-5 %-Lösung bei aktinischer KeratosePotassium hydroxide 5 % solution in actinic keratosis. Der Hautarzt 72:11, pages 975-983.
Crossref
Crossref
Daniel B. Eisen, Maryam M. Asgari, Daniel D. Bennett, Suzanne M. Connolly, Robert P. Dellavalle, Esther E. Freeman, Gary Goldenberg, David J. Leffell, Sue Peschin, James E. Sligh, Peggy A. Wu, Lindsy Frazer-Green, Sameer Malik & Todd E. Schlesinger. (2021) Guidelines of care for the management of actinic keratosis: Executive summary. Journal of the American Academy of Dermatology 85:4, pages 945-955.
Crossref
Crossref
Daniel B. Eisen, Maryam M. Asgari, Daniel D. Bennett, Suzanne M. Connolly, Robert P. Dellavalle, Esther E. Freeman, Gary Goldenberg, David J. Leffell, Sue Peschin, James E. Sligh, Peggy A. Wu, Lindsy Frazer-Green, Sameer Malik & Todd E. Schlesinger. (2021) Guidelines of care for the management of actinic keratosis. Journal of the American Academy of Dermatology 85:4, pages e209-e233.
Crossref
Crossref
Thais Cristina Mendonça Nogueira & Marcus Vinicius Nora de Souza. (2021) New FDA oncology small molecule drugs approvals in 2020: Mechanism of action and clinical applications. Bioorganic & Medicinal Chemistry 46, pages 116340.
Crossref
Crossref
Sachin Bhagchandani, Jeremiah A. Johnson & Darrell J. Irvine. (2021) Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants. Advanced Drug Delivery Reviews 175, pages 113803.
Crossref
Crossref
Sukhjit Dhariwal, Tushar Hari, Kamal Kaur, Chamandeep Thind, Alison Bedlow, Bruce C Gee & Simon Tso. (2020) Virtual consultation for actinic keratosis. BJGP Open 4:4, pages bjgpopen20X101126.
Crossref
Crossref
Lawrence S. Moy, Debra Frost & Stephanie Moy. (2020) Photodynamic Therapy for Photodamage, Actinic Keratosis, and Acne in the Cosmetic Practice. Facial Plastic Surgery Clinics of North America 28:1, pages 135-148.
Crossref
Crossref
Edward W. Seger, Isadore S. Tarantino, Brett C. Neill & Ting Wang. (2019) Relative Efficacy of Nonoperative Treatment of Keratoacanthomas. Journal of Cutaneous Medicine and Surgery 24:1, pages 41-46.
Crossref
Crossref
Alisen Huang, Julie K. Nguyen, Evan Austin, Andrew Mamalis & Jared Jagdeo. (2019) Updates on Treatment Approaches for Cutaneous Field Cancerization. Current Dermatology Reports 8:3, pages 122-132.
Crossref
Crossref
A. Rosenthal, M. Stoddard, L. Chipps & J. Herrmann. (2019) Skin cancer prevention: a review of current topical options complementary to sunscreens. Journal of the European Academy of Dermatology and Venereology 33:7, pages 1261-1267.
Crossref
Crossref
Andrew M. Armenta, Emily D. Henkel & Ammar M. Ahmed. (2019) Pigmentation Disorders in the Elderly. Drugs & Aging 36:3, pages 235-245.
Crossref
Crossref
I. Longo & C. Serra-Guillén. (2018) Quality of Life, Behaviour and Attitudes towards Actinic Keratosis in Spain: The PIQA Study. Actas Dermo-Sifiliográficas (English Edition) 109:4, pages 331-339.
Crossref
Crossref
I. Longo & C. Serra-Guillén. (2018) Calidad de vida, comportamiento y actitudes hacia la queratosis actínica en España: estudio PIQA. Actas Dermo-Sifiliográficas 109:4, pages 331-339.
Crossref
Crossref
Neal Bhatia. (2017) Management of Actinic Keratosis. Current Dermatology Reports 6:4, pages 279-287.
Crossref
Crossref
Uwe Reinhold. (2017) A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis. Future Oncology 13:27, pages 2413-2428.
Crossref
Crossref
P. Arenberger & M. Arenbergerova. (2017) New and current preventive treatment options in actinic keratosis. Journal of the European Academy of Dermatology and Venereology 31, pages 13-17.
Crossref
Crossref
T. Dirschka, G. Pellacani, G. Micali, J. Malvehy, A.J. Stratigos, A. Casari, L. Schmitz & G. Gupta. (2017) A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index. Journal of the European Academy of Dermatology and Venereology 31:8, pages 1295-1302.
Crossref
Crossref
Germano Piccirillo, Brigida Bochicchio, Antonietta Pepe, Katja Schenke-Layland & Svenja Hinderer. (2017) Electrospun poly-l-lactide scaffold for the controlled and targeted delivery of a synthetically obtained Diclofenac prodrug to treat actinic keratosis. Acta Biomaterialia 52, pages 187-196.
Crossref
Crossref
Eggert Stockfleth, Ralph von Kiedrowski, Rolf Dominicus, John Ryan, Adam Ellery, Meritxell Falqués, Nathalie Ivanoff & Rosario Rodriguez Azeredo. (2016) Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial. Dermatology and Therapy 7:1, pages 81-96.
Crossref
Crossref
Praven Chetty, Felix Choi & Timothy Mitchell. (2015) Primary Care Review of Actinic Keratosis and Its Therapeutic Options: A Global Perspective. Dermatology and Therapy 5:1, pages 19-35.
Crossref
Crossref
Peter A. Lio, Toral Patel, Neill T. Peters & Sarah KasprowiczPeter A. Lio, Toral Patel, Neill T. Peters & Sarah Kasprowicz. 2015. Handbook of Integrative Dermatology. Handbook of Integrative Dermatology
35
51
.
B. Dréno, J.M. Amici, N. Basset‐Seguin, B. Cribier, J.P. Claudel & M.A. Richard. (2014)
Management of actinic keratosis: a practical report and treatment algorithm from
AKT
eam
TM
expert clinicians
. Journal of the European Academy of Dermatology and Venereology 28:9, pages 1141-1149.
Crossref
Crossref
Annabel Dodds, Alvin Chia & Stephen Shumack. (2014) Actinic Keratosis: Rationale and Management. Dermatology and Therapy 4:1, pages 11-31.
Crossref
Crossref
Katherine A. Lyseng-Williamson & Gillian M. Keating. (2014) Ingenol mebutate gel: a guide to its use in actinic keratosis in the EU. Drugs & Therapy Perspectives 30:5, pages 155-160.
Crossref
Crossref
. (2013) Management of actinic keratosis. Drug and Therapeutics Bulletin 51:7, pages 81-84.
Crossref
Crossref